Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of ARCL Organics
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 46.44 | 41.58 | 43.25 | 48.33 | 57.57 | 59.93 | 56.46 | 61.96 | 72.24 | 67.34 | 86.19 | 53.47 | 65.31 |
| Expenses + | 40.12 | 38.42 | 39.51 | 41.20 | 52.27 | 54.14 | 51.19 | 58.14 | 63.29 | 60.87 | 74.77 | 53.79 | 58.22 |
| Operating Profit | 6.32 | 3.16 | 3.74 | 7.13 | 5.30 | 5.79 | 5.27 | 3.82 | 8.95 | 6.47 | 11.42 | -0.32 | 7.09 |
| OPM % | 13.61% | 7.60% | 8.65% | 14.75% | 9.21% | 9.66% | 9.33% | 6.17% | 12.39% | 9.61% | 13.25% | -0.60% | 10.86% |
| Other Income + | 2.25 | 0.43 | 0.64 | 0.81 | 0.82 | 0.41 | 0.71 | 0.83 | 0.40 | 0.83 | 1.18 | 0.59 | 0.78 |
| Interest | 0.51 | 0.51 | 0.69 | 1.39 | 0.48 | 1.08 | 1.08 | 0.98 | 1.07 | 0.99 | 0.84 | 1.38 | 1.75 |
| Depreciation | 1.30 | 1.33 | 1.29 | 1.17 | 0.50 | 1.37 | 1.13 | 1.29 | 1.42 | 1.39 | 1.49 | 1.51 | 1.63 |
| Profit before tax | 6.76 | 1.75 | 2.40 | 5.38 | 5.14 | 3.75 | 3.77 | 2.38 | 6.86 | 4.92 | 10.27 | -2.62 | 4.49 |
| Tax % | 74.26% | -12.00% | 47.92% | 29.37% | 1.95% | 26.13% | 42.44% | 24.37% | 18.51% | 18.70% | 29.70% | 236.26% | 37.86% |
| Net Profit + | 1.74 | 1.96 | 1.25 | 3.80 | 5.04 | 2.77 | 2.18 | 1.79 | 5.60 | 3.99 | 7.22 | -8.81 | 2.79 |
| EPS in Rs | 2.18 | 2.45 | 1.56 | 4.75 | 6.30 | 3.46 | 2.72 | 2.24 | 7.00 | 4.99 | 9.02 | -11.01 | 3.49 |
Financials of ARCL Organics
Annual income statement trend
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 71 | 71 | 87 | 141 | 165 | 191 | 251 | 272 |
| Expenses + | 67 | 64 | 74 | 126 | 147 | 171 | 227 | 248 |
| Operating Profit | 4 | 7 | 12 | 15 | 18 | 19 | 24 | 25 |
| OPM % | 6% | 9% | 14% | 11% | 11% | 10% | 10% | 9% |
| Other Income + | 1 | 1 | 2 | 2 | 3 | 3 | 2 | 3 |
| Interest | 2 | 3 | 2 | 1 | 2 | 3 | 4 | 5 |
| Depreciation | 1 | 1 | 1 | 1 | 3 | 4 | 5 | 6 |
| Profit before tax | 1 | 3 | 11 | 15 | 17 | 15 | 17 | 17 |
| Tax % | 26% | 24% | 28% | 29% | 30% | 23% | 26% | 70% |
| Net Profit + | 1 | 3 | 8 | 11 | 12 | 11 | 12 | 5 |
| EPS in Rs | 1.39 | 3.15 | 10.05 | 13.16 | 14.59 | 14.12 | 15.41 | 6.49 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of ARCL Organics
Capital structure and asset base
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 14 | 16 | 24 | 35 | 46 | 58 | 69 | 74 |
| Borrowings + | 20 | 17 | 9 | 15 | 20 | 29 | 34 | 71 |
| Other Liabilities + | 15 | 13 | 27 | 41 | 46 | 63 | 57 | 67 |
| Total Liabilities | 57 | 55 | 68 | 98 | 120 | 157 | 169 | 220 |
| Fixed Assets + | 22 | 21 | 20 | 27 | 46 | 63 | 68 | 97 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 35 | 34 | 48 | 71 | 74 | 94 | 101 | 123 |
| Total Assets | 57 | 55 | 68 | 98 | 120 | 157 | 169 | 220 |
Financials of ARCL Organics
Operating, investing and financing cash movement
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -2 | 6 | 6 | 2 | 25 | 13 | 5 | -4 |
| Cash from Investing Activity + | -4 | -0 | -1 | -7 | -22 | -21 | -9 | -34 |
| Cash from Financing Activity + | 7 | -5 | -4 | 5 | 4 | 7 | 2 | 32 |
| Net Cash Flow | 0 | 0 | 1 | -1 | 7 | -1 | -2 | -5 |
| Free Cash Flow | -7 | 5 | 5 | -6 | 3 | -8 | -5 | -39 |
| CFO/OP | -55% | 90% | 60% | 26% | 152% | 66% | 22% | -7% |
Financials of ARCL Organics
Working capital efficiency and return ratios
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 87 | 87 | 96 | 82 | 71 | 66 | 75 | 56 |
| Inventory Days | 35 | 45 | 40 | 43 | 38 | 58 | 28 | 45 |
| Days Payable | 51 | 43 | 89 | 88 | 105 | 130 | 90 | 79 |
| Cash Conversion Cycle | 71 | 89 | 48 | 37 | 4 | -6 | 14 | 22 |
| Working Capital Days | 2 | 32 | 48 | 41 | 16 | 19 | 21 | 2 |
| ROCE % | 15% | 32% | 33% | 28% | 21% | 20% | 17% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…